vTv Therapeutics Inc (VTVT)
23.70
-0.07
(-0.29%)
USD |
NASDAQ |
May 31, 16:00
23.95
+0.25
(+1.05%)
After-Hours: 20:00
vTv Therapeutics 1 Year Total Returns (Daily): -25.00% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -25.00% |
| May 30, 2024 | -26.32% |
| May 29, 2024 | -30.54% |
| May 28, 2024 | -27.88% |
| May 24, 2024 | -18.47% |
| May 23, 2024 | -17.52% |
| May 22, 2024 | -17.38% |
| May 21, 2024 | -20.30% |
| May 20, 2024 | -22.50% |
| May 17, 2024 | -26.37% |
| May 16, 2024 | -22.56% |
| May 15, 2024 | -24.66% |
| May 14, 2024 | -22.73% |
| May 13, 2024 | -22.97% |
| May 10, 2024 | -30.12% |
| May 09, 2024 | -22.01% |
| May 08, 2024 | -18.29% |
| May 07, 2024 | -17.24% |
| May 06, 2024 | -18.16% |
| May 03, 2024 | -26.17% |
| May 02, 2024 | -25.00% |
| May 01, 2024 | -10.88% |
| April 30, 2024 | -9.42% |
| April 29, 2024 | -8.51% |
| April 26, 2024 | -9.27% |
| Date | Value |
|---|---|
| April 25, 2024 | -11.27% |
| April 24, 2024 | -14.99% |
| April 23, 2024 | -17.35% |
| April 22, 2024 | -19.13% |
| April 19, 2024 | -20.92% |
| April 18, 2024 | -17.54% |
| April 17, 2024 | -21.09% |
| April 16, 2024 | -18.50% |
| April 15, 2024 | -15.56% |
| April 12, 2024 | -14.87% |
| April 11, 2024 | -14.70% |
| April 10, 2024 | -14.61% |
| April 09, 2024 | -18.83% |
| April 08, 2024 | -18.83% |
| April 05, 2024 | -19.78% |
| April 04, 2024 | -18.53% |
| April 03, 2024 | -21.53% |
| April 02, 2024 | -20.93% |
| April 01, 2024 | -22.01% |
| March 28, 2024 | -26.47% |
| March 27, 2024 | -23.72% |
| March 26, 2024 | -27.16% |
| March 25, 2024 | -31.89% |
| March 22, 2024 | -31.30% |
| March 21, 2024 | -6.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.20%
Minimum
May 16 2022
148.1%
Maximum
Sep 17 2019
-11.21%
Average
-15.20%
Median
Sep 16 2021
1 Year Total Returns (Daily) Benchmarks
| Amgen Inc | 42.95% |
| Eli Lilly and Co | 92.42% |
| Altimmune Inc | 85.89% |
| Viking Therapeutics Inc | 183.7% |
| Rhythm Pharmaceuticals Inc | 114.2% |